Home / malaysiang

malaysiang

OMERS Infrastructure Agrees to Purchase 19.4% Stake in Azure Power

Transaction expands Canadian pension plan’s direct investment holdings in India, while increasing its global exposure to renewables sector SINGAPORE, July 30, 2021 (GLOBE NEWSWIRE) — OMERS Infrastructure today announced that it has signed a Stock Purchase Agreement to acquire from International Finance Corporation and IFC GIF Investment Company I an approximately 19.4% stake in Azure […]

Read More »

RISULTATI DEL SECONDO TRIMESTRE 2021

The following is an extract from the “CNH Industrial 2021 second quarter results” press release. The complete press release can be accessed by visiting the media section of the CNH Industrial corporate website: https://www.cnhindustrial.com/en-us/media/press_releases/Pages/default.aspx or consulting the accompanying PDF: CNH Industrial reports strong second quarter performance. Consolidated revenues of $8.9 billion (up 60% compared to […]

Read More »

AKWEL: TURNOVER INCREASES 26% IN THE FIRST HALF OF 2021

        Thursday 29 July 2021 TURNOVER INCREASES 26% IN THE FIRST HALF OF 2021 AKWEL (FR0000053027, AKW, PEA-eligible), the automotive and HGV equipment and systems manufacturer specialising in fluid management and mechanisms, has posted consolidated turnover of €487.6m in the first half of 2021, up by 26.0% compared to the first half of the previous […]

Read More »

Junshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has accepted its supplemental New Drug Application (sNDA) for toripalimab in combination with platinum-containing chemotherapy […]

Read More »

Fortinet Reports Second Quarter 2021 Financial Results

Second Quarter 2021 Highlights Total revenue of $801.1 million, up 30% year over year Product revenue of $298.3 million, up 41% year over year Service revenue of $502.8 million, up 24% year over year Billings of $960.9 million, up 35% year over year1 Deferred revenue of $2.91 billion, up 27% year over year GAAP operating […]

Read More »

DARE-19 Phase III Collaboration between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile Was Consistent in Patients with COVID-19

OVERLAND PARK, KS, July 29, 2021 (GLOBE NEWSWIRE) — The findings of DARE-19, a double-blind, placebo-controlled Phase III trial examining Dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19, have been published in The Lancet Diabetes & Endocrinology.  The study was a collaboration of  George Clinical, a global scientifically-backed clinical research organization and Saint Luke’s […]

Read More »

FALANA & FALANA Issues the Following Statement: Detention of a Wrong Person Nullifies Detention

WASHINGTON, July 29, 2021 (GLOBE NEWSWIRE) — In its judgment of March 15, 2021 the Ecowas Court of Justice detailed the extensive violations of Cape Verdean law (along with international law) that occurred in the arrest and detention of Alex Saab. Consequently, the Court issued a binding unanimous decision in which it declared that Alex […]

Read More »